Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999
The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.
Grundy SM, Cleeman JI, Rifkind BM, Kuller LH, . Cholesterol Lowering in the Elderly Population. Arch Intern Med. 1999;159(15):1670-1678. doi:10.1001/archinte.159.15.1670